Recurrent Ovarian Cancer Patient Study
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at how patients with ovarian cancer that has come back take part in research. It helps doctors better understand patient experiences and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been told your ovarian cancer has come back (recurrent)
- You can understand what the study is about and agree to join
- You can do regular online reports (using a computer, tablet, or phone)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a targeted treatment, chosen based on tumor biology, can help people with recurrent ovarian cancer. You may be asked to give a tumor biopsy so researchers can analyze specific “signal” activity in your cancer.
This trial tests two experimental drugs, AK104 and AK112, for ovarian cancer that has come back after standard platinum chemotherapy. It may be an option if your cancer is a high-grade type and you have had prior treatment.
This trial asks men with recurrent prostate cancer to share their experiences during treatment. Your participation could help doctors better understand what patients go through when cancer comes back.
This study looks at the real-world experiences of patients with ovarian cancer, whether newly diagnosed or with persistent or recurrent disease. It aims to learn more about the disease and its treatment over time.
This study tests if personalized treatment plans, based on detailed genetic testing of your tumor, can help women with recurrent ovarian, cervical, or endometrial cancer. You will work with a team of specialists to find the best options for you.
This trial tests a new drug called NTB-928 for people with ovarian cancer that has come back or stopped responding to treatment. The goal is to see if the drug can help when standard treatments are no longer working well.
Hear when a new Recurrent Ovarian Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.